Optimization of the Care Pathway for Patients With Chronic Pain: Assessing the Value of Integrating Sleep Specialists
RecruitingNot applicableNCT06052384
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
DOLOREPIT is an interventional, RIPH 2, multicenter, randomized, controlled, open-label study comparing two care pathways for the management of patients with chronic pain.
Study details
- Official title
- Optimisation du Parcours de Soins Des Patients Atteints de Douleurs Chroniques : étude randomisée évaluant l'intérêt de l'intégration Des spécialistes du Sommeil
- Conditions
- Interventions
- Other: Standard pain management combined with sleep disorder management
- Sponsor
- Centre Hospitalier Emile Roux
- Start date
- 2023-12-07
- Primary completion
- 2027-06
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- France
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * First consultation at the pain management center * Patient with chronic pain as defined by the "Haute Autorité de Santé". The pain must have several of the following characteristics: * Persistence or recurrence * Duration beyond what is usual for the presumed initial cause, especially if the pain has been evolving for more than 3 months; * Inadequate response to treatment; * Important and progressive deterioration of the patient's functional and interpersonal abilities in activities of daily living at home, school, or work due to the pain. * Patients with chronic primary pain (according to the typology defined by the International Classification of Diseases-11) and classified into one of the 4 following categories: * Chronic generalized pain * Complex regional pain syndrome * Chronic primary headache or orofacial pain * Chronic primary musculoskeletal pain * Pittsburgh Sleep Quality Index (PSQI) must be completed by the patient and the score must be available (for randomization purposes) * Have access to an internet connection as a self-administered questionnaire is to complete online, and at least have access to the online platform for CBT treatment if insomnia is detected * Affiliation to a French social security system * Free informed consent Exclusion Criteria: * Patients undergoing cancer treatment or who have completed treatment within the last 2 years * Patient with a chronic inflammatory disease (e.g. rheumatoid arthritis, ankylosing spondylitis, chronic inflammatory bowel disease, Horton's disease, Wegener's disease, myositis, Still's disease, lupus erythematosus, etc.) * Immunocompromised patient * Patient with severe psychiatric pathology that does not allow study follow-up (at the discretion of the investigator) * Patient already treated for a sleep disorder by a sleep specialist (the only prescription of hypnotics is not considered as a criterion of non-inclusion) * Patient follow-up difficult (for geographic motives or other reasons) * Patient under judicial protection of incapable adults or guardianship * Refusal to participate in the research
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06052384